Yi-Cheng Lin

Investigation of dual antiplatelet therapy after coronary stenting in patients with chronic kidney disease

Tzu-Hao Chang, C. Kao, Mai-Szu Wu, 2021, PloS one.

Effectiveness and safety of rivaroxaban versus warfarin in Taiwanese patients with end-stage renal disease and nonvalvular atrial fibrillation: A real-world nationwide cohort study

Yi-Cheng Lin, Chih-Wei Chen, L. Chien, 2021, PloS one.

Reply: Optimal Dose of Rivaroxaban in Asians With Atrial Fibrillation: Further Studies Are Warranted.

Yi-Cheng Lin, L. Chien, Chun-Yao Huang, 2018, Journal of the American College of Cardiology.

Association of multiple preventive therapies postdischarge and long-term health outcomes after acute myocardial infarction

Yi-Cheng Lin, Chih-Wei Chen, Wan-Ting Chen, 2021, Journal of the Chinese Medical Association : JCMA.

Effectiveness and Safety of Standard- and Low-Dose Rivaroxaban in Asians With Atrial Fibrillation.

Yi-Cheng Lin, Chih-Wei Chen, Wan-Ting Chen, 2018, Journal of the American College of Cardiology.

Reply

Yi-Cheng Lin, L. Chien, Chun-Yao Huang, 2018, Journal of the American College of Cardiology.

Renal outcomes after contrast exposure in patients with diabetes who use sodium-glucose cotransporter 2 inhibitors.

Ming-Tsang Chuang, Yi-Cheng Lin, Chun-Yao Huang, 2023, Postgraduate medical journal.

Low‐dose aspirin for prevention of cardiovascular mortality in patients with type 2 diabetes and chronic kidney disease: A real‐world nationwide cohort study

Yi-Cheng Lin, Chun-Yao Huang, Wan-Ting Chen, 2023, Journal of Diabetes Investigation.